Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
The Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina at Chapel Hill (NC, USA) is a collaborative, multidisciplinary unit that brings together faculty from different disciplines and crosses the traditional departmental/school structure to perform pharmacogenomics research. IPIT investigators work together towards the goal of developing therapies to enable the delivery of individualized medical care. The NIH-supported Comprehensive Research on Expressed Alleles in Therapeutic Evaluation (CREATE) group leads the field in the evaluation of pathways regulating drug activity, and also provides a foundation for future IPIT research. IPIT members perform bench research, clinical cohort analysis and prospective clinical intervention studies, research on the integration of pharmacogenomic therapy into practice and research to foster global health pharmacogenomics application through the Pharmacogenetics for Every Nation Initiative. IPIT Investigators are actively incorporating a pharmacogenomics curriculum into existing teaching programs at all levels.
Rakhra-Burris
Tejinder K
TK
UNC Institute for Pharmacogenomics & Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7361, USA.
Auman
J Todd
JT
Deverka
Patricia
P
Dressler
Lynn G
LG
Evans
James P
JP
Goldberg
Richard M
RM
Havener
Tammy M
TM
Hoskins
Janelle M
JM
Jonas
Daniel E
DE
Long
Kevin M
KM
Motsinger-Reif
Alison A
AA
Irvin
William J
WJ
Richards
Kristy L
KL
Roederer
Mary W
MW
Valgus
John M
JM
Riper
Marcia van
Mv
Vernon
John A
JA
Zamboni
William C
WC
Wagner
Michael J
MJ
Walko
Christine M
CM
Weck
Karen E
KE
Wiltshire
Tim
T
McLeod
Howard L
HL
D000047:Academies and Institutes; D035843:Biomedical Research; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D008967:Molecular Biology; D009657:North Carolina; D010597:Pharmacogenetics / Q000193:education; D057285:Precision Medicine; D034741:RNA, Small Interfering; D016032:Randomized Controlled Trials as Topic; D013629:Tamoxifen / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D034741:RNA, Small Interfering; D013629:Tamoxifen; D014859:Warfarin